FDA Clearance Tracker · K252348
Tomey Optical Biometer OA-2000 (OA-2000)
Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2025
Substantially Equivalent
Time to decision
142 days
Received Jul 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K252348
- Device name
- Tomey Optical Biometer OA-2000 (OA-2000)
- Applicant
- Tomey Corporation
- Applicant location
- Nagoya, JP
- Received
- Jul 29, 2025
- Decided
- Dec 18, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Device, Analysis, Anterior Segment (MXK)
- Device class
- Class II
- Regulation
- 21 CFR 886.1850
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MXK. The earliest in FDA's data is K984443, decided Mar 5, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252348
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Tomey Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250553 · Decided Jul 18, 2025 · 143 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K213265 · Decided Apr 27, 2022 · 209 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K171313 · Decided Jan 19, 2018 · 260 days after receipt
Device type: Microscope, Specular (NQE) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.